Wolfe Research initiated coverage of Stryker with an Outperform rating and $405 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- Stryker price target raised to $374 from $360 at BTIG
- Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
- Stryker announces agreement to acquire Vertos Medical
- Stryker to participate in the 2024 Wells Fargo Healthcare Conference
